Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
The control rate of pancreatic cancer is 85%! The powerful new drug AB680 is better than the standard care plan 21/06/2022 pancreatic cancer CD73 gene
How to improve long-term survival rates in hepatocellular carcinoma? Novel dual immunotherapy shows promising first-line efficacy. 07/06/2022 肝細胞癌 HCC
